Poster (10)
51.
Poster
Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. Vaccine Technology VII, Mont Tremblant, Canada (2018)
52.
Poster
Unravelling the Interplay between Protein O-Mannosylation and N-Glycosylation - A Glycomic and Glycoproteomic Study of Human N-Cadherin. DFG FOR 2509 Meeting, Höchst (Odenwald), Germany (2018)
53.
Poster
Modeling reveals changes in key parameters of infuenza A virus replication in engineered cell lines. 11th Annual International Conference on Systems Biology of Human Diseases, Los Angeles, USA (2018)
54.
Poster
CCE: The EB66 (R) Cell line for Yellow Fever Vaccine procustion at high cell concentrations. Cell Culture Engineering XVI, Tampa, Florida, USA (2018)
55.
Poster
Flavivirus production in perfusion processes using the EB66 (R) Cell line. Vaccine Technology VII, Mont Tremblant, Canada (2018)
56.
Poster
A multiscale model of influenza A virus replication covering highly different infection conditions in cell cultures. Foundations of Systems Biology in Engineering - 7th FOSBE 2018, Oak Brook, Illinois, USA (2018)
57.
Poster
A step towards globally affordable vaccines & gene therapies: Steric exclusion chromatography as a capture platform. Recovery of Biological Products, Asheville, USA (2018)
Thesis - Diploma (1)
58.
Thesis - Diploma
Untersuchung zum Einfluss des Probenzustandes und der Probenbehandlung auf den HbA1e-Messwert bei der Verwendung der POC Analysengeräte Quo-Lab und Quo-Test. Diploma, Otto-von-Guericke-Universität, Magdeburg (2018)
Thesis - Master (11)
59.
Thesis - Master
Der Einfluss von Prozessparametern auf die mikrobiellen Gemeinschaften von Biogasanlagen. Master, Otto-von-Guericke-Universität, Magdeburg (2018)
60.
Thesis - Master
Advanced Development of sugar nucleotide regeneration cascade. Master, Universidade de Nova Lisboa, Lissabon, Portugal (2018)
61.
Thesis - Master
Establishment of human 3D respiratory tissue models to study influenza A virus infection. Master, Universität Konstanz, Konstanz (2018)
62.
Thesis - Master
Austestung eines LC-MS/MS basierten Workflows für die Metaproteomuntersuchung von mikrobiellen Gemeinschaften in Biogasanlagen. Master, TU Berlin, Berlin (2018)
63.
Thesis - Master
Development of a Cascade of Immobilized Enzymes for Production of Activated Sugar. Master, KTH Stockholm, Stockholm, Sweden (2018)
64.
Thesis - Master
Intracellular Stochastic Modelling of Influenza A Virus and DIP Replication. Master, Universidade NOVA, Lisboa (2018)
65.
Thesis - Master
Establishment of qPCR methods for the analysis of recombinant CHO DG44 cells by miRNA, mRNA and gene copy number quantification. Master, Otto-von-Guericke-Universität, Magdeburg (2018)
66.
Thesis - Master
Long-term propagation of influenza A virus and defective interfering viral paricles dS1(1). Master, Otto-von-Guericke-Universität, Magdeburg (2018)
67.
Thesis - Master
Identifizierung von neu-synthetisierten, mikrobiellen Proteinen in Biogasanlagenproben in Abhängigkeit verschiedener Substrate mittels Klick-Chemie und Metaproteomanalyse. Master, Otto-von-Guericke Universität, Magdeburg (2018)
68.
Thesis - Master
Einfluss des Prozessierungsstatus von Emtagenomdaten auf die Identifizierung von Proteinen mittels Massenspektrometrie. Master, Otto-von-Guericke-Universität, Magdeburg (2018)
69.
Thesis - Master
Development of four sandwich ELISAs for monitoring process optimization for a cell culture-based tetravalent vaccine. Master, Otto-von-Guericke-Universität, Magdeburg (2018)
Thesis - Bachelor (3)
70.
Thesis - Bachelor
Biogas-Anlagen Simulation mit Aspen. Bachelor, Otto-von-Guericke-Universität, Magdeburg (2018)
71.
Thesis - Bachelor
Abhängigkeit der Auflösung der Metaproteomanalyse von dem Typ des Massenspektrometers und der Messmethode. Bachelor, Otto-von-Guericke-Universität, Magdeburg (2018)
72.
Thesis - Bachelor
Untersuchung des biologischen Abbaus von Phosphonaten mittels Proteomanalyse. Bachelor, Otto-von-Guericke-Universität, Magdeburg (2018)
Editorial (1)
73.
Editorial
36 (22), pp. 3061 - 3063 (2018)
Vaccine Technology VI: Innovative and integrated approaches in vaccine development. Vaccine